Celldex Therapeutics, Inc. – Trademark Portfolio

Entity Type: 03

Celldex Therapeutics, Inc. holds 36 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 35 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 5 are pending. Notable registered marks include CELLDEX and CELLDEX THERAPEUTICS. The owner is based in Bloomsbury, NJ.

519 Route 173 West

Bloomsbury, NJ 08804

36 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (36 results)

Trademark Classifications

Celldex Therapeutics, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (35 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does Celldex Therapeutics, Inc. have?

Celldex Therapeutics, Inc. has 36 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 pending, 21 abandoned, 7 cancelled.

What trademark classes does Celldex Therapeutics, Inc. file in?

Celldex Therapeutics, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Celldex Therapeutics, Inc.'s most well-known trademarks?

Celldex Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as CELLDEX and CELLDEX THERAPEUTICS. These are among 3 currently registered trademarks in the portfolio.

What is Celldex Therapeutics, Inc.'s trademark registration success rate?

Celldex Therapeutics, Inc. has a 10% trademark registration rate, with 3 out of 31 resolved applications resulting in successful registration. Currently, 5 applications are pending review.